{
  "ticker": "WNX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02975430",
  "id": "02975430",
  "pages": 9,
  "price_sensitive": true,
  "date": "20250731",
  "time": "1611",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250731/pdf/06md60l2gm2p5v.pdf",
  "summary": "### **Wellnex Life Limited \u2013 Quarterly Report (Appendix 4C) \u2013 Key Material Information**  \n\n#### **Financial & Operational Highlights:**  \n- **Sales**: $6.6M (Q4 FY25), up **22% YoY** (Q3 FY25: $5.4M).  \n  - Brand sales: $4.9M (+19.5% YoY).  \n  - IP Licensing: $1.7M (+30.8% YoY).  \n- **Cash receipts**: $6.5M (flat vs. Q3 FY25).  \n- **Net cash flow from operations**: **$0.98M** (vs. $0.04M in Q3 FY25).  \n- **Gross margin improvement**: 2H FY25 gross margin at **37%** (vs. 23% in 1H FY25).  \n- **Closing cash balance**: **$0.5M** (down from $5.3M prior quarter).  \n\n#### **Capital & Financing Updates:**  \n- **New debt facility**: **$2.825M secured** (24-month term, 14% interest), partially funded by a related-party director ($825K).  \n- **Existing facility adjustment**: Reduced ScotPac facility to **$3.8M** (from $5.3M), with **$1.1M undrawn**.  \n- **Use of proceeds**: Margin enhancement (bulk inventory purchase, raw material acquisition).  \n\n#### **Strategic Initiatives:**  \n- Divested non-core assets (The Iron Company).  \n- Internal review ongoing to optimise revenue/profitability.  \n\n**No material information omitted; all key trading/financial metrics extracted.**",
  "usage": {
    "prompt_tokens": 5218,
    "completion_tokens": 357,
    "total_tokens": 5575,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-31T06:35:15.431462"
}